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Objectives:  To assess sleep duration-mortality relationships across a 27-year follow-up 
period in a well characterized random sample of older people, and to test the hypothesis that 
mortality risks associated with long sleep duration confound with, and can be explained by, 
low levels of functional capacity indicative of frailty.  
Methods: Face-to-face interviews conducted among 1002 randomly sampled older (65+) 
people in 1985 provided baseline profiles of health, functional capacity, physical activity, and 
sleep quality and duration.  Health and functional status in each of 6 sleep duration 
categories (≤4, 5, 6, 7, 8, ≥9 hours) was examined.  At censorship in 2012, 927 deaths were 
recorded.  Relationships between sleep duration and 27-year all-cause mortality were then 
examined in a series of incrementally adjusted Cox regression models.  
Results:  Associations between sleep duration and measures of sleep quality were 
predominantly linear, with longer sleep times indicating superior sleep quality. Relationships 
between sleep duration and functional capacity, on the other hand, were predominantly 
quadratic, with most approximating a U-shaped function. Adjusted for age, gender, social 
class, insomnia symptoms, physical health, depression, BMI and smoking status, long sleep 
duration and continuous hypnotic drug use at baseline were significantly and independently 
associated with elevated mortality risk (HR: 1.37; 95% CI: 1.05-1.78; HR: 1.24; 95% CI: 
1.01-1.51).  When indices of frailty were added to the model, hazard ratios for long sleep 
duration and hypnotic drug became non-significant, while the lowest physical activity quintile 
and very slow walking speed significantly increased mortality risk (HR: 1.79; 95% CI: 1.40-
2.30; HR: 1.41; 95% CI: 1.15-1.73 respectively).   
Conclusions:  In analyses of sleep-related mortality outcomes long sleep durations confound 
with, and may be indicative of, incipient frailty among older participants.         
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Introduction 
Subjectively reported long and short sleep durations have been consistently associated with 
increased all-cause mortality (e.g. Kripke et al, 2002; Patel et al, 2004; Ferrie et al, 2007; 
Ikehara et al, 2009; Castro-Costa et al, 2011; Kakizaki et al, 2013; Chen, Su & Chou, 2013; 
Aurora et al, 2016), with meta analyses (Gallicchio and Kalesan, 2009; Cappuccio et al, 
2010) suggesting a U-shaped sleep duration-mortality function. However, this U-shaped 
function has been reported mainly in studies where participants are asked to estimate an 
average or ‘typical’ total sleep time (TST).  Studies where TST has been calculated (by the 
investigator) from reported bedtimes, rise times, and sleep latencies have tended to show a 
stronger relationship between long sleep duration and mortality (Kurina et al, 2013).  It is 
likely that ‘normative bias’ (where participants in good health are inclined to report socially 
‘normal’ sleep durations and vice-versa) is reduced using the latter method (Kurina et al, 
2013).  While longer sleep durations have been associated with an increased risk of incident 
diabetes, cardiovascular disease, stroke, coronary heart disease, and obesity (Jike et al, 
2018), causal pathways linking longer TSTs to mortality risk remain under researched 
(Knutson & Turek, 2006; Grandner & Drummond, 2007; Patel et al, 2012).    
  Longer sleep durations could influence health and survival through the independent risks 
associated with sedentary behavior (see Thorp et al, 2011) and inactive lifestyles (see 
Samitz et al, 2011) since: a) longer sleep times, of necessity, reduce the time available for 
active behavior; and b) longer sleep times logically demand an extended time in bed (TIB) 
which may attract the same health risks as persistent sedentary behavior.  Evidence 
consistent with these assumptions is provided by: the Nurses’ Health Study II (Patel et al, 
2006), which found longer sleep durations associated with both mortality and lower activity 
levels; the National Health Interview Survey which found both higher activity levels 
associated with a lower risk of long (but not short) sleep durations (Krueger & Friedman, 
2009), and that increased stroke prevalence associated with long (relative to short) sleep 
durations was mitigated by regular moderate physical activity (Seixas et al, 2018); and the 
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combined Swedish Male and Swedish Mammography cohorts study (Bellavia et al, 2014) 
which found that long sleep durations were significantly associated with all-cause mortality in 
the least physically active sub-group. None of these studies, however, reported analyses 
which controlled for TIB.   
   Similarly emphasizing physical activity, the emergence of frailty in later life may also 
contribute to long sleep-mortality relationships (Lee et al, 2014; 2017).  Defined as “…a state 
of vulnerability to poor resolution of homoeostasis after a stressor event” (Clegg et al, 2013), 
frailty does not necessarily reflect active disease processes, but is indexed rather to the 
cardinal signs of: self-reported exhaustion; low physical activity; slow walking speed; muscle 
weakness (as indicated by grip strength); and shrinking/weight loss (Afilalo et al, 2014). Both 
frail (where any 4 of these signs co-occur) and ‘prefrail’ (where any 2 of these signs co-
occur) states have been shown to be predictive of mortality in models adjusted for age and 
self-reported mental and physical health status (Fried et al, 2001).  Given this, longer sleep 
durations (and consequently longer TIBs) could reflect signs of ‘exhaustion’ and ‘low 
physical activity’ indicative of prefrail states in otherwise healthy individuals. Consistent with 
this, longer TIBs have been shown to significantly increase the risk of subsequent cognitive 
(Gabelle et al, 2017) and physical (Stenholm et al, 2011) decline in older people.   
  In the present analyses we combine detailed indices of functional capacity with established 
health and demographic covariates in models designed to evaluate sleep duration-mortality 
relationships across one of the longest follow-up periods yet reported for a random sample 
of older people.  In addition, the analyses aimed: 1) to examine the longitudinal stability of 
survey-assessed TST categories; and 2) to characterize functional capacity, health and 
sleep quality profiles across sleep duration categories.  
METHODS 
Data were derived from the Nottingham Longitudinal Study of Activity and Ageing (NLSAA), 
full details of which are presented elsewhere (Morgan, 1998).  Briefly, the NLSAA is an 
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ongoing study of health outcomes among people originally aged 65 and over living in the 
UK. The baseline survey for the NLSAA was conducted between May and September 1985, 
during which time 1042 people, randomly sampled from the community, were interviewed in 
their own homes.  Follow-up surveys were conducted in 1989 and 1993, with re-interview 
rates of 88% and 73% respectively obtained among survivors. Information on mortality within 
the baseline sample was provided by the UK Medical Research Information Service and 
handled by KM and IH as accredited Office of National Statistics (ONS) Approved 
Researchers.  Survey waves and subsequent analyses were approved by relevant ethical 
agencies. Survey assessments relevant to the present analyses are described below.   
 
Physical activity 
Customary physical activity (CPA) was assessed in 6 domains: indoor; outdoor; leisure; 
walking; strength; and flexibility. Continuous activities performed for at least 3 minutes/week 
for at least the previous six weeks were aggregated into total minutes/week. Prior to the 
assessment of walking participants were asked “Which of the following best describes your 
(typical) walking speed?”, with the options: very slow; stroll at an easy pace; normal speed; 
fairly brisk; and fast.  Non-continuous activities likely to contribute to muscle strength or joint 
flexibility were assessed in terms of frequency of performance.  Principal components 
analysis of activity in all 6 domains extracted factor scores providing valid and reliable 
summary measurements of physical activity in this population (Morgan, 1998; Hartescu, 
Morgan & Stevinson, 2015). For the survival analyses, activity was coded as a categorical 
variable using CPA1 quintile ranges to define low, medium low, medium, medium high, and 
high (reference) customary physical activity levels.     
Total Sleep Time (TST) and Time in Bed (TIB) 
Sleep duration and TIB were calculated from the items: 1) “At what time do you usually go to 
bed?”; 2) “At what time do you usually settle down in bed to go to sleep?”; 3) How long does it 
normally take you to fall asleep?”; 4) “At what time do you finally wake up?”; and 5) “At what 
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time do you usually get up?” (TST = TIB minus all non-sleep time in bed).  Sleep duration 
(TST) values were categorized in 1-hour units and rounded to the nearest whole number 
ranging from ≤4 hours to ≥9 hours (after Chen et al, 2013).  Time in bed (TIB = time elapsed 
between going to bed and getting up) was similarly estimated in whole hours ranging from ≤6 
hours to ≥10 hours.  In common with previous studies (e.g. Kripke et al, 2002; Youngstedt and 
Kripke, 2004; Chen et al, 2013) the TST reference category was 7 hours.  The TIB reference 
category was 8 hours.   
Insomnia symptoms 
Sleep quality was assessed using the item "Do you ever have problems sleeping (i.e. 
problems getting to sleep and/or staying asleep and/or waking too early?)", with five 
response categories (never, seldom, sometimes, often, all the time).  Positive responses 
were followed with the question “Have you had this problem/these problems in the past 
week?”.  Insomnia symptoms were considered present if the participant reported a sleep 
problem "often" or "all the time", and if that problem had been experienced within the 
previous week.  The incidence and prevalence of insomnia symptoms assessed using 
these items closely matched epidemiological expectations (see Morgan, 2003).    
Muscle strength 
Maximum handgrip strength (in newtons) was assessed using a purpose-designed isometric 
dynamometer (Bassey, 1998). The highest value from 3 maximal attempts using either hand 
was used as the definitive measurement. Values in the lowest gender-specific quintile were 
categorized as ‘frail’; all other values were categorized as ‘non-frail’.    
Weight and Skeletal Size   
At interview weight measurements (fully clothed with shoes removed) were made using 
calibrated analogue scales. To reduce error arising from kyphotic changes in measuring the 
height of older people, skeletal size was assessed using demi span, the distance between the 
finger roots and the sternal notch (with the arm laterally outstretched). BMI was then estimated 
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using weight and predicted height (Lehmann et al, 1991) and categorized: <18.5 
(underweight); >18.5 to <25 (healthy); ≥25 overweight/obese. 
 
Hypnotic drug use 
Prescription hypnotic drug use was assessed with the item “Do you take prescribed medicines 
to help you sleep”.  Reported hypnotic use was verified by the interviewer who examined 
tangible evidence of prescribed medication. Responses were categorized: continuous user; 
occasional user; and non-user.   
Physical Health Status   
General physical health was assessed using a health index scored from zero (low health 
burden) to 13 (high health burden) covering the presence or absence of: heart, stomach, 
eyesight, or foot problems; giddiness, headaches, urinary incontinence, arthritis, falls, 
and chronic disease; drug use (excluding hypnotics) and walking aid use, and recent (1 
month) contact with (primary and secondary care) medical services. Smoking status 
(smoker v non-smoker) was assessed in a separate item. 
Mental Health Status 
Affective status was assessed using the Symptoms of Anxiety and Depression (SAD) Scale 
(Bedford et al, 1976).  Clinically significant levels of depressive symptoms are indicated by 
scores of ≥6. At baseline, scores at or above this cut-point showed high levels of concordance 
with clinical diagnostic ratings of depression (Morgan 1998). 
Social Class 
Social/occupational class (Elias et al, 1993) was based on main occupation (or husband’s main  
occupation) before retirement, and collapsed into 3 categories: 1 (professional/managerial); 2 
(skilled manual/non-manual); and 3 (semi-/unskilled manual). 
Statistical analyses 
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Indices of sleep quality (including time spent in bed and sleep efficiency), physical 
activity, and physical capabilities (handgrip strength and shoulder flexibility) across the 
reported sleep duration categories were examined in regression models to test for linear 
and quadratic relationships.  Associations between baseline sleep duration category and 
the prevalence of insomnia symptoms and hypnotic drug use were assessed using chi-
square.  Concordance between membership of baseline and subsequent 4- and 8-year 
follow-up sleep duration categories was assessed using Cohen’s kappa.   
Relationships between reported sleep durations and all-cause mortality were examined in 
four separate Cox regression models with days from baseline interview (a date between May 
1st – September 30th, 1985) to death/censorship (9th February 2012) as dependent.  In the 
first model we adjusted only for age and gender (Model 1). Two further models then 
incrementally adjusted for: social class; hypnotic drug use; insomnia symptoms; physical 
health; depression; BMI; and smoking status (Model 2); and physical activity quintile; very 
slow walking speed; frail handgrip strength; and TIB category (Model 3). Interaction terms 
(physical activity by sleep duration, physical activity by gender, and physical activity by time 
in bed) initially added to Models 3 & 4 were non-significant, and omitted from the final 
models.  In all models age was entered as a categorical variable for the 5-year bands (65-
69; 70-74; 75-79; ≥80). To formally test the proportional hazards (PH) assumption 
Schoenfeld’s residuals were calculated for each covariate and regressed against survival 
time; results showed no significant departures from the PH assumption.  To address issues 
of possible reverse causality (where health status at baseline might influence both sleep 
variables and mortality hazard), Models1-3 were repeated omitting deaths recorded within 3 
years of the baseline interview. A forced entry approach to model selection was used 
throughout.  All data were analyzed using SPSS for Windows v23.0.  
 
RESULTS 
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From the baseline sample of 1002, 42 participants were omitted due to incomplete activity 
data (n = 14), incomplete anthropometric data (n = 12), or withholding permission for this 
element of the study (n = 18).  In the 27-year period 1985-2012 the project received 
notification of 927 deaths within the remaining sample of 960. Demographic and sleep 
characteristics, together with follow-up concordance levels, are shown across sleep duration 
categories in Table 1.  The mean total sleep time was 7.1 hours (SD 1.5 hours), with most 
(52.9%) participants reporting 6-8 hours sleep.  At both the 4 and 8 years follow-ups, sleep 
duration categories among survivors showed a significant degree of concordance with those 
calculated at baseline (kappa = 0.16, p<0.001; and kappa = 0.13, p<0.001 respectively), with 
percentage agreement within categories ranging from 20-40% (Table 1).  In analyses 
collapsing these categories into shorter (≤ 5 hours), intermediate (6-8 hours) and longer (> 8 
hours) sleep durations, percentage agreement at the 4-year (kappa = 0.29, p<0.001) and 8-
year (kappa = 0.16, p<0.001) follow-ups ranged from 40-60%.  Associations between sleep 
duration and measures of sleep quality (Table 1) were predominantly linear, with longer 
sleep times significantly associated with longer periods spent in bed (F = 326.1; df = 1, 958; 
p<0.001), higher sleep efficiency (F = 934.1; df = 1, 958; p<0.001), and a lower likelihood of 
reporting insomnia symptoms (chi-square = 58.21, df = 5, p<0.001). Relationships between 
sleep duration and health and physical activity outcomes, on the other hand, were 
predominantly quadratic, with most approximating a U-shaped function (Table 2).  
Participants sleeping either more or less than 6-8 hours showed the lowest levels of overall 
physical activity (chi square = 42.4, df = 20, p<0.01), and the lowest levels of handgrip 
strength and general health (all p<0.01; Table 2). Depression showed a less consistent 
relationship with sleep duration, though high levels of clinical symptoms were associated 
with the shortest (≤4 hours) sleep, while those with the longest sleep durations (>9 hours) 
reported the lowest levels of depression (Table 2).  A significant negative correlation was 
found between TIB as a continuous variable and CPA1 scores (rho = -0.18; n = 960; 
p<0.001), though the correlation between TST and CPA1 scores and was not significant (rho 
= 0.03; n = 960; p=0.33).    
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   Hazard ratios (HR) and confidence intervals (CI) for all-cause mortality from the Cox 
regression analyses are shown in Table 3.   Adjusted only for age and gender, Model 1 
shows that those who slept for ≥ 9 hours had a significantly elevated risk of mortality over 
the 27-year follow-up period (HR: 1.4; 95% CI 1.08-1.83). This level of hazard associated 
with long sleep duration was only marginally attenuated when mental and physical health 
confounders were added in Model 2 (HR = 1.37; 95% CI: 1.05-1.78).  Within this model 
hypnotic usage was also associated with significant risk (HR: 1.24; 95% CI: 1.01-1.51; Table 
3). Following the addition of TIB category, physical activity level, handgrip strength  and 
walking speed in Model 3, the risk associated with long (≥ 9 hours) sleep duration was no 
longer significant (HR: 1.18; 95% CI: 0.85-1.63), while the lowest quintile for physical activity, 
and the slowest walking speed were both associated with significantly elevated mortality risk 
(HR: 1.79; 95% CI: 1.40-2.30; HR: 1.41; 95% CI: 1.15-1.73 respectively; Table 3).  Excluding 
deaths in the first 3 years after baseline, the association with mortality hazard remained 
significant for long sleep duration across models 1 and 2, and for the lowest physical activity 
quintile (HR: 046; 95% CI: 1.07-1.99) and very slow walking speed (HR: 1.33; 95% CI: 1.05-
1.68) in Model 3 (see Table 4).  Continuous hypnotic usage did not emerge as a significant 
mortality risk in any of the analyses omitting mortality in the first 3 years. Insomnia was not 
significantly associated with mortality in models using either the full follow-up data, or 
omitting mortality in the first 3 years. 
 
DISCUSSION 
The present findings from a nationally representative sample are strengthened by 
interviewer-assessed profiles of sleep quantity and quality, validated survey measures of 
mental and physical health, physical capacities, and physical activity levels, follow-up sleep 
assessments demonstrating significant stability in the reported sleep duration categories, 
and a large number of accurately recorded deaths.  The proportions represented in the sleep 
duration categories (Table 1) are also comparable with those found in similarly aged 
samples (Castro-Costa et al, 2011; Chen et al, 2013), while the average sleep time of 7.1 
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hours calculated for the whole sample falls between that reported for older people in Brazil 
(Castro-Costa et al, 2011) and Taiwan (Chen et al, 2013), 7.2 and 6.3 hours respectively.  
These results, therefore, offer a detailed and authoritative profile of sleep, activity and health 
at baseline, and a robust test of the influence of functional status on sleep duration-mortality 
relationships.    
   In general, increases in sleep duration were associated with superior sleep quality, with 
those in the longer (7, 8 and ≥ 9 hours) sleep duration categories reporting the shortest 
sleep latencies, the highest sleep efficiency scores, and the lowest levels of insomnia 
symptoms (Table 1). Indices of health and functional ability, on the other hand, showed a 
more u-shaped relationship with TST, with those in the ≤4 hours category showing the 
highest levels of depression and physical health problems, and those in the ≥9 hours 
category showing the lowest levels of activity.  These findings accord with the results of 
Castro-Costa et al (2011) for physical and mental health, and Stranges et al (2008) and 
Bellavia et al (2014) for daytime physical activity. In addition, and over one of the longest 
follow-up periods yet reported for a random sample of older people, the present results align 
with earlier findings (e.g. Castro-Costa et al, 2011; Chen et al, 2013; Kurina et al, 2013; 
Bellavia, 2014) showing that longer (rather than shorter) sleep durations are more strongly 
associated with elevated all-cause mortality risk in models adjusted for mental and physical 
health status.  
   The unique contributions of the present study, however, are to show: 1) that long (≥ 9 
hours) sleepers are characterized by low levels of daily exercise, low muscle strength, and 
very slow walking speeds (all indicative of prefrailty/frailty); and 2) that two of these attributes 
(low levels of physical activity and very slow walking speed) are associated with elevated 
mortality risk even after controlling for long sleep duration, mental and physical health status, 
insomnia symptoms and hypnotic drug use.  A reasonable inference to draw from these 
results is that indices of functional ability indicative of prefrail and frail states contribute to the 
phenomenon of long sleep duration-mortality relationships.  Our analyses also confirm the 
supposition that these indices of functional status are inadequately captured (and controlled 
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for) by conventional survey measures of health status.  Nevertheless, the present results do 
appear to be at variance with Lee et al’s (2017) recent finding that prefrailty and long sleep 
durations were significant but independent predictors of mortality. Several factors suggest 
these reported differences may principally reflect differing methodologies.  Relative to the 
Lee et al (2017) study, our analyses: included an older population (≥53 years v ≥65 years); 
used a substantially longer follow-up period (4.7 years v 27 years); consequently captured 
more deaths (72 v 927); used more TST categories as covariates (3 v 6); employed a 
different threshold for long sleep duration (≥8 hours v ≥ 9 hours); and controlled for TIB. That 
said, it should also be emphasized that the HRs for long sleep duration in the present 
Models 2 and 3 were quite similar, even though the latter failed to achieve significance.   
  In conclusion, then, the present findings from the survival models (Table 3), together with 
health and activity profiles (Table 2) suggest a high degree of confounding among the TST 
and functional capacity covariates. While we would broadly agree with Kurina et al (2013) 
that ambiguities in the causal pathway from TST to mortality make it difficult to distinguish 
between confounders and mediators, the pattern of results shown here is consistent with the 
conclusion that very low levels of daytime activity, very slow walking speeds, and longer 
times spent in bed provide candidate factors plausibly contributing, directly or indirectly, to 
longer term mortality risk among those sleeping ≥ 9 hours.   Such a conclusion is also in 
agreement with Bellavia et al’s (2014) suggestion that comorbidity with low physical activity 
might, at least in part, explain long sleep - mortality relationships.  However, caution in 
interpreting the influence of the CPA1 in the survival models reported here is appropriate. In 
contrast to the findings of Bellavia et al (2014), which classified long sleep as ≥ 8 hours, the 
present analyses found no significant interaction between physical activity and TST in 
predicting mortality.   
   Evidence of a reciprocal relationship between daily activity level and TIB was provided by 
the significant, though modest negative correlation between these variables (rho = -0.18; n = 
960; p<0.001) indicating diminishing daytime activity as TIB increased (though again, the 
TIB-CPA1 interaction term was not significant in predicting mortality).  Evidence that TIB 
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might independently compromise health is provided by the InChianti study (Stenholm et al, 
2011) which found that both total sleep time and time in bed predicted accelerated decline in 
physical functioning among older people 3 and 6 years after baseline assessments.  Taken 
together, therefore, the present results suggest that the activity and TIB profiles, and the 
mortality outcomes of those in the longest (≥ 9 hours) sleep duration category, could be 
indicative of incipient frailty. The possibility also remains that the inactivity characteristic of 
frailty states may, in itself, attract the health risks associated with sedentary behavior.    
   Finally, several factors, arising both from the design of the present study, and the present 
outcomes, should be recognized as limitations.  Designed at a time when clinical awareness 
of obstructive sleep apnea (OSA) was just developing in the UK (see, for example, Shapiro 
et al, 1981), the protocol did not include questions on snoring or daytime sleepiness which 
could have contributed to better characterizing the sleep symptoms reported here. While 
unequivocally a limitation, we concur with Cappuccio et al (2010, pp 590) who concluded 
that OSA-related mortality risk would most likely arise in obese shorter sleepers, and that 
“…adjustment for obesity or body mass index… would have corrected for this.” 
While we are confident that the present findings extend earlier studies of subjectively 
reported nighttime sleep, the impact of total 24-hour sleep on mortality hazard, and the 
relationship of such risk to sleep obtained outwith the night-time sleep period remains to be 
investigated.   
   We also acknowledge the evident limitations of extrapolating from analyses performed on 
data collected from an earlier generation of older people.  Reductions in physical activity 
levels, and increases in levels overweight/obesity seen in recent decades (Health and Social 
Care Information Centre, 2014) could have introduced generational or cohort effects which 
impacted the key variables reported here and, as a result, possibly limit the contemporary 
relevance of the findings.  However, while these trends may have influenced the overall 
levels of, for example, the BMI and activity variables, it is less clear how secular change 
would impact relationships between these variables and health outcomes. That the 
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relationships identified in this study accord with contemporary findings drawn from more 
recent cohorts supports the validity of the conclusions drawn. 
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Table 1  Demographic and sleep characteristics at baseline by sleep duration  
 Sleep duration (hours) 
 
 
 
 
≤4 
 
5 
 
6 
 
7 
 
8 
 
≥9 
 
P 
 
Total = 960: n (%)   
 
94  (9.8) 
 
126 (13.1) 
 
228 (23.8) 
 
279 (29.1) 
 
161 (16.8) 
 
72 (7.5) 
 
 
Gender  
       
  
Women: n (%)  
 
66 (11.3) 
 
87 (14.9) 
 
133 (22.7) 
 
154 (26.3) 
 
100 (17.1) 
 
45 (7.7) 
 
  
Men: n (%)  
 
28 (7.5) 
 
39 (10.4) 
 
95 (25.3) 
 
125 (33.3) 
 
61 (16.3) 
 
27 (7.2) 
 
<0.05† 
 
Age: mean (median/range) 
 
76 (75/29) 
 
75 (74/29) 
 
74 (74/28) 
 
75 (75/30) 
 
76 (75/26) 
 
77 (77/33) 
 
0.03‡ 
 
Social Class N (%) 
       
  
Professional/managerial 
 
12 (8.1) 
 
15 (10.1) 
 
42 (28.4) 
 
46 (31.1) 
 
24 (16.2) 
 
9 (6.1) 
 
  
Skilled manual/non-manual 
 
57 (10.0) 
 
87 (15.2) 
 
125 (21.9) 
 
157 (27.5) 
 
100 (17.5) 
 
45 (7.9) 
 
  
Semi-/unskilled manual 
 
25 (10.4) 
 
24 (10.0) 
 
61 (25.3) 
 
76 (31.5) 
 
37 (15.4) 
 
18 (7.5) 
 
0.45† 
 
Time in bed (TIB) hours: mean (SD) 
 
8.2 (1.5) 
 
8.0 (1.4) 
 
8.4 (1.1) 
 
8.8 (0.8) 
 
9.5 (0.9) 
 
10. 8 (1.1) 
 
<0.001* 
 
Sleep Latency minutes: mean (SD) 
 
53 (40.1) 
 
36.8 (35.8) 
 
25.1 (27.9) 
 
18.0 (19.3) 
 
15.8 (19.6) 
 
16.4 (15.6) 
 
<0.001* 
 
Sleep efficiency (SE): mean (SD) 
 
53.0 (15.1) 
 
73.1 (12.2) 
 
80.3 (9.5) 
 
87.3 (7.0) 
 
90.63 (6.93) 
 
92.5 (5.9) 
 
<0.001* 
 
Prevalent insomnia symptoms: n 
 
column (%) 
 
45 (22.8) 
 
28 (14.2) 
 
48 (24.4) 
 
42 (21.3) 
 
23 (11.7) 
 
11 (5.6) 
 
<0.001† 
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Hypnotic use: n (%)  
  
Non-user 
 
68 (9.1) 
 
98 (13.1) 
 
172 (23.1) 
 
227 (30.4) 
 
132 (17.7) 
 
49 (6.8) 
 
  
Occasional user 
 
11 (13.8) 
 
14 (17.5) 
 
22 (27.5) 
 
17 (21.3) 
 
9 (11.3) 
 
7 (8.8) 
 
  
Continuous user 
 
15 (11.2) 
 
14 (10.4) 
 
34 (25.4) 
 
35 (26.1) 
 
20 (14.9) 
 
16 (11.9) 
 
0.10† 
 
 
  
 
Survivors in same sleep duration 
  
category at 4-year follow-up: n 
 
(column %) 
 
19 (31.1) 
 
23 (26.7) 
 
47 (29.9) 
 
80 (40.2) 
 
32 (28.6) 
 
12 (30.8) 
 
<0.001§ 
  
Survivors in same sleep duration 
category at 8-year follow-up: n 
(column %) 
 
 
10 (22.7) 
 
 
10 (20.8) 
 
 
33 (32.7) 
 
 
43 (39.8) 
 
 
16 (25.4) 
 
 
5 (26.3) 
 
 
<.001§ 
Percentages are row values unless stated otherwise; SD, Standard Deviation; † significance of chi-square; ‡  Significance of Kruskal-Wallis 
1-way ANOVA; § Significance of Cohen’s kappa; *significance of regression F-value testing goodness of fit of linear model 
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Table 2  Activity and health profiles at baseline by sleep duration  
 Sleep duration (hours) 
 
 
 
 
≤4 
 
5 
 
6 
 
7 
 
8 
 
≥9 
 
P 
 
Customary Physical Activity Score  
 
Quintiles: n (%) 
       
  
Low activity 
 
25 (26.6) 
 
26 (20.6)  
 
47 (20.6) 
 
39 (14.0) 
 
26 (16.1) 
 
22 (30.6) 
 
  
Medium/low activity 
 
23 (24.5) 
 
21 (16.7) 
 
41 (18.0) 
 
46 (16.5) 
 
40 (24.8) 
 
25 (34.7) 
 
  
Medium activity activity 
 
16 (17.0) 
 
25 (19.8) 
 
44 (19.3) 
 
65 (23.3) 
 
29  (18.0) 
 
10 (13.9) 
 
  
Medium/high activity 
 
15 (16.0) 
 
27 (21.4) 
  
43 (18.9) 
 
68 (24.4) 
 
35 (21.7) 
 
8 (11.1) 
 
  
High activity 
 
15 (16.0) 
 
27 (21.4) 
 
53 (23.2) 
 
61 (21.9) 
 
31 (19.3) 
 
7 (9.7) 
 
0.003† 
 
Typical walking speed “very slow”: n (%) 
 
19 (20.4) 
 
26 (20.6) 
 
44 (19.5) 
 
44 (15.8) 
 
37 (23.0) 
 
30 (42.3) 
 
0.001† 
 
Maximum handgrip in newtons: mean  (SD) 
 
 
234.1 
 
(101.8) 
 
242.6  
 
(99.6) 
 
264.8 
 
(109.3) 
 
266.5  
 
(97.1) 
 
254.6 
 
(101.5) 
 
231.3 
 
(89.4) 
 
<0.001‡ 
 
Maximum handgrip in lowest quintile: n (%)  
 
27 (28.7)
  
 
23 (19.0) 
 
38 (17.4) 
 
44 (16.1) 
 
35 (23.3) 
 
18 (27.3) 
 
<0.001‡ 
 
BMI: n (%) 
       
  
<18.5 - underweight 
 
7 (7.4) 
 
14 (11.1) 
 
19 (8.3) 
 
21 (7.5) 
 
14 (8.7) 
 
7 (9.7) 
 
  
>18.5 to <25 - normal 
 
43 (45.7) 
 
62 (49.2) 
 
112 (49.1) 
 
157 (56.3) 
 
76 (47.2) 
 
41 (56.9) 
 
24 
 
  
≥25 - overweight 
 
44 (46.8) 
 
50 (39.7) 
 
97 (42.5) 
 
101 (36.2) 
 
71 (44.1) 
 
24 (33.3) 
 
0.56† 
 
Health Index: mean (SD)§ 
 
 
5.4 (2.6) 
 
4.6 (2.8) 
 
4.4 (2.7) 
 
4.0 (2.5) 
 
4.1 (2.5) 
 
5.0 (2.6) 
 
<0.01‡ 
Survey classification of  
 
depression: n (column %) 
 
18 (19.1) 10 (7.9) 21 (9.2) 13 (4.7) 18 (11.2) 9 (12.5) 0.001† 
 
Percentages are row values; SD, Standard Deviation; † Significance of chi-square; ‡ Significance of regression F-value testing goodness of fit 
of quadratic model; §Higher scores indicate greater health burden  
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Table 3  Hazard ratios (HR) from Cox regression models*: all-cause mortality at 27-year follow-up  
Covariate 
 
No. of 
 
deaths 
Model 1 Model 2 Model 3 
        
Sleep duration 
 
 HR (95% CI) P 
 
HR (95% CI) P 
 
HR (95% CI) P 
  
≤4 hours  
 
 
92 
 
1.02 (0.80-1.29) 
 
0.89 
 
1.02 (0.80-1.31) 
 
0.87 
 
1.08 (0 .83-1.4) 
 
0.58 
 5 hours  
 
123                            1.04 (0.84-1.29) 0.72 1.02 (0.82-1.27)                              0.85 1.01 (0.79-1.29) 0.91 
 6 hours  
 
221 1.00 (0.84-1.20) 0.97 1.00 (0.83-1.20) 0.97 0.97 (0.80-1.18) 0.77 
 7 hours  
 
270 Reference  Reference  Reference  
 8 hours  
 
150 0.89 (0.73-1.09) 
 
0.26 0.90 (0.74-1.11) 0.32 0.88 (0.71-1.10) 0.27 
 ≥9 hours   
 
71 1.40 (1.08-1.83) 0.01 1.37 (1.05-1.78) 0.02 1.18 (0.85-1.63) 0.32 
Hypnotic use        
  
Non-user 
 
 
720 
   
Reference 
  
Reference 
 
 Occasional user 76   0.87 (0.69-1.13) 
 
0.33 0.83 (0.64-1.07) 
 
0.15 
  
Continuous user 
 
131 
   
1.24 (1.01-1.51) 
 
0.04 
 
1.19 (0.96-1.47) 
 
0.11 
 
Activity level 
       
  
Low 
 
182 
     
1.79 (1.40-2.30) 
 
<0.01 
  
Medium low 
 
190 
     
1.16 (0.92-1.46) 
 
0.46  
26 
 
  
Medium 
 
182 
     
1.14 (0.91-1.41) 
 
0.68 
  
Medium  
 
high 
 
187 
     
1.07 (0.86-1.34) 
 
0.58 
  
High 
 
186 
    Reference  
 
Time in bed 
 
       
 ≤6 hours 
 
76     0.99 (0.74-1.31) 0.91 
 7 hours  
 
189     0.98 (0.81-1.19) 0.84 
 8 hours  
 
323     Reference  
 9 hours 
 
208     1.19 (0.98-1.43) 0.08 
 ≥10 hours 
   
100     1.03 (0.78-1.35) 0.86 
Handgrip  
Strength 
 
       
 Lowest quintile 180     1.05 (0.87-1.26) 0.62 
Walking speed 
 
       
 Very slow 173     1.41 (1.15-1.73) <0.01 
 
*Covariates for Model 1: age and gender; Model 2: as Model 1 plus social class, hypnotic drug use, insomnia symptoms, physical health, 
symptoms of depression, BMI, and smoking status; Model 3: as Model 2 plus physical activity quintile; very slow walking speed; frail handgrip 
strength; and TIB category.   
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Table 4  Hazard ratios (HR) from Cox regression models* excluding deaths in the first 3 years post baseline: all-cause mortality at 27-year 
follow-up 
Covariate 
 
No. of 
 
deaths 
Model 1 Model 2 Model 3 
Sleep duration        
 
 
 
≤4 hours  
 
 
72 
 
0.98 (0.75-1.28) 
 
0.9 
 
0.98 (0.74-1.29) 
 
0.88 
 
1.04 (0.78-1.39) 
 
0.79 
 5 hours  
 
106 1.12 (0.89-1.42) 0.35 1.11 (0.88-1.41) 0.39 1.11 (0 .85-1.45) 0.43 
 6 hours  
 
182 1.01 (0.83-1.23) 0.67 1.02 (0.83-1.25) 0.86 0.99 (0.80-1.23) 0.93  
 7 hours  
 
218 Reference  Reference  Reference  
 8 hours  
 
118 0.85 (0.68-1.07) 0.16 0.87 (0.67-1.10) 0.23 0.87 (0 .67-1.11) 0.26 
 ≥9 hours   
 
51 1.37 (1.01-1.87) 0.04 1.40 (1.00-1.86) 0.05 1.29 (0 .89-1.86) 0.18 
 
Activity level 
       
 Low 122 
 
    1.46 (1.07-1.99) 0.02 
 Medium low 160 
 
    1.09 (0 .83-1.41) 0.54 
 Medium 161 
 
    1.08 (0 .84-1.37) 0.57 
 Medium high 169     1.08 (0 .85-1.38) 0.51 
 
 High 168     Reference 
 
 
Walking speed  
 
      
 Very low 116     1.33 (1.05-1.68) 0.02 
28 
 
 
  
*Covariates for Model 1: age and gender; Model 2: as Model 1 plus social class, hypnotic drug use, insomnia symptoms, physical health, 
symptoms depression, BMI, and smoking status; Model 3: as Model 2 plus physical activity quintile; very slow walking speed; frail handgrip 
strength; and TIB category. 
 
